Lilly obesity drug beats Novo in study
Tirzepatide 3x more likely to result in https://seekingalpha.com/news/4040661-eli-lilly-weight-loss-drug-outperforms-novo-nordisk?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study vs. semaglutide. (0:15) Consumer https://seekingalpha.com/news/4040744-consumer-confidence-bounces-back-after-three-straight-monthly-declines?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study pick up sharply in November. (1:38) Amazon takes https://seekingalpha.com/news/4040633-amazon-overtakes-ups-and-fedex-to-become-biggest-delivery-giant-in-the-us?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study from UPS, FedEx. (3:50) Show Notes https://seekingalpha.com/news/4040610-hedge-funds-ease-up-on-magnificent-7-binge?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study https://seekingalpha.com/news/4040629-adobe-figma-deal-likely-result-in-substantial-lessening-of-competition?source=wsb_podcast:lilly_obesity_drug_beats_novo_in_study...
show moreShow Notes
Hedge funds ease up on Magnificent 7 binge
Adobe, Figma deal likely to result in 'substantial lessening of competition'
Episode transcripts seekingalpha.com/wsb.
Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.
Information
| Author | Seeking Alpha |
| Website | seekingalpha.com |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
